These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 24486594)

  • 81. The prognostic importance of miR-21 in stage II colon cancer: a population-based study.
    Kjaer-Frifeldt S; Hansen TF; Nielsen BS; Joergensen S; Lindebjerg J; Soerensen FB; dePont Christensen R; Jakobsen A;
    Br J Cancer; 2012 Sep; 107(7):1169-74. PubMed ID: 23011541
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Reduced expression of a gene proliferation signature is associated with enhanced malignancy in colon cancer.
    Anjomshoaa A; Lin YH; Black MA; McCall JL; Humar B; Song S; Fukuzawa R; Yoon HS; Holzmann B; Friederichs J; van Rij A; Thompson-Fawcett M; Reeve AE
    Br J Cancer; 2008 Sep; 99(6):966-73. PubMed ID: 19238634
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Cancer stem cell gene profile as predictor of relapse in high risk stage II and stage III, radically resected colon cancer patients.
    Giampieri R; Scartozzi M; Loretelli C; Piva F; Mandolesi A; Lezoche G; Del Prete M; Bittoni A; Faloppi L; Bianconi M; Cecchini L; Guerrieri M; Bearzi I; Cascinu S
    PLoS One; 2013; 8(9):e72843. PubMed ID: 24023782
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Clinical Significance of a Gene Signature Generated from Tumor Budding Grade in Colon Cancer.
    Shinto E; Yoshida Y; Kajiwara Y; Okamoto K; Mochizuki S; Yamadera M; Shiraishi T; Nagata K; Tsuda H; Hase K; Kishi Y; Ueno H
    Ann Surg Oncol; 2020 Oct; 27(10):4044-4054. PubMed ID: 32328985
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Integrative genomics reveals hypoxia inducible genes that are associated with a poor prognosis in neuroblastoma patients.
    Applebaum MA; Jha AR; Kao C; Hernandez KM; DeWane G; Salwen HR; Chlenski A; Dobratic M; Mariani CJ; Godley LA; Prabhakar N; White K; Stranger BE; Cohn SL
    Oncotarget; 2016 Nov; 7(47):76816-76826. PubMed ID: 27765905
    [TBL] [Abstract][Full Text] [Related]  

  • 86. An online gene expression assay for determining adjuvant therapy eligibility in patients with stage 2 or 3 colon cancer.
    Van Laar RK
    Br J Cancer; 2010 Dec; 103(12):1852-7. PubMed ID: 21119668
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Young-Onset Colon Cancer and Recurrence Risk by Gene Expression.
    Chang GJ; You YNY; Russell CA; Tierno MB; Turner M; Bennett JP; Lau A; Hochster HS
    J Natl Cancer Inst; 2020 Nov; 112(11):1170-1173. PubMed ID: 32040172
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Integrated analysis of multiple microarray datasets identifies a reproducible survival predictor in ovarian cancer.
    Konstantinopoulos PA; Cannistra SA; Fountzilas H; Culhane A; Pillay K; Rueda B; Cramer D; Seiden M; Birrer M; Coukos G; Zhang L; Quackenbush J; Spentzos D
    PLoS One; 2011 Mar; 6(3):e18202. PubMed ID: 21479231
    [TBL] [Abstract][Full Text] [Related]  

  • 89. A molecular signature for Epithelial to Mesenchymal transition in a human colon cancer cell system is revealed by large-scale microarray analysis.
    Joyce T; Cantarella D; Isella C; Medico E; Pintzas A
    Clin Exp Metastasis; 2009; 26(6):569-87. PubMed ID: 19340593
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Improving the Prognosis of Colon Cancer through Knowledge-Based Clinical-Molecular Integrated Analysis.
    Tong D; Tian Y; Ye Q; Li J; Ding K; Li J
    Biomed Res Int; 2021; 2021():9987819. PubMed ID: 33928165
    [TBL] [Abstract][Full Text] [Related]  

  • 91. L1TD1 - a prognostic marker for colon cancer.
    Chakroborty D; Emani MR; Klén R; Böckelman C; Hagström J; Haglund C; Ristimäki A; Lahesmaa R; Elo LL
    BMC Cancer; 2019 Jul; 19(1):727. PubMed ID: 31337362
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Decreased expression of MS4A12 inhibits differentiation and predicts early stage survival in colon cancer.
    He L; Deng HY; C Wang X
    Neoplasma; 2017; 64(1):65-73. PubMed ID: 27881006
    [TBL] [Abstract][Full Text] [Related]  

  • 93. A circRNA signature predicts postoperative recurrence in stage II/III colon cancer.
    Ju HQ; Zhao Q; Wang F; Lan P; Wang Z; Zuo ZX; Wu QN; Fan XJ; Mo HY; Chen L; Li T; Ren C; Wan XB; Chen G; Li YH; Jia WH; Xu RH
    EMBO Mol Med; 2019 Oct; 11(10):e10168. PubMed ID: 31475771
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Screening of Differentiation-Specific Molecular Biomarkers for Colon Cancer.
    Qi L; Ding Y
    Cell Physiol Biochem; 2018; 46(6):2543-2550. PubMed ID: 29742509
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Glycosyltransferase expression in human colonic tissue examined by oligonucleotide arrays.
    Kemmner W; Roefzaad C; Haensch W; Schlag PM
    Biochim Biophys Acta; 2003 Jun; 1621(3):272-9. PubMed ID: 12787925
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Adjuvant Therapy for Colon Cancer: Genes, Genes… and the Patient in the Center.
    Rodriguez J; Vicent S; Chopitea A; Ponz-Sarvisé M
    Clin Cancer Res; 2018 Aug; 24(16):3787-3789. PubMed ID: 29678903
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Genetic analysis of advanced colon cancer of 8 mm with liver metastasis.
    Nosho K; Yamamoto H; Suzuki C; Niinuma T; Satoh A; Yoshida M; Nakahara S; Goto A; Yamashita K; Yoshida Y; Adachi Y; Arimura Y; Endo T; Hirata K; Imai K
    Int J Colorectal Dis; 2005 Jan; 20(1):81-2. PubMed ID: 15322837
    [No Abstract]   [Full Text] [Related]  

  • 98. Prognostic factors in patients with stage II colon cancer: Role of E-selectin gene polymorphisms.
    Turpin A; Labreuche J; Fléjou JF; Andre T; de Gramont A; Hebbar M
    Dig Liver Dis; 2019 Aug; 51(8):1198-1201. PubMed ID: 31221547
    [No Abstract]   [Full Text] [Related]  

  • 99. Complement C1QC as a potential prognostic marker and therapeutic target in colon carcinoma based on single-cell RNA sequencing and immunohistochemical analysis.
    Deng H; Chen Y; Liu Y; Liu L; Xu R
    Bosn J Basic Med Sci; 2022 Oct; 22(6):912-922. PubMed ID: 35765947
    [TBL] [Abstract][Full Text] [Related]  

  • 100. A predictive risk probability approach for microarray data with survival as an endpoint.
    Chen DT; Schell MJ; Chen JJ; Fulp WJ; Eschrich S; Yeatman T
    J Biopharm Stat; 2008; 18(5):841-52. PubMed ID: 18781520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.